Medicinal adhesive for percutaneous administration

• US 5,505,956 A
• Filed: 04/01/1994
• Issued: 04/09/1996
• Est. Priority Date: 11/30/1992
• Status: Expired due to Term

• Current Assignee: Pacific Pharmaceutical Co., Ltd. (AmorePacific Group, Inc.)
• Original Assignee: Pacific Chemical Co., Ltd.
• Inventors: Lee, Woo Y., Kim, Jung J., Han, Sang H., Ahn, Jong W.
• Primary Examiner(s): Phelan, D. Gabrielle
• Application Number:
  US08/186,925
• Time in Patent Office: 739 Days
• Field of Search: 424/448, 424/449
• US Class Current: 424/448
• CPC Class Codes: A61K 9/7053 obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
• CPC Class Codes: A61K 9/7061 Polyacrylates
• CPC Class Codes: A61K 9/7076 the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
• CPC Class Codes: A61K 9/7092 Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Abstract

Disclosed herein is a medicinal adhesive for percutaneous administration of a drug consisting of a support (backing layer), an adhesive layer comprising an oil-soluble drug, an adhesive resin, a penetration enhancer, a water-absorptive material and a lenitive agent, and a separate liner, charaterized in that the adhesive layer has a laminated structure having 2 to 5 layers and each layer has different water absorption capacities, and the drug is a oil-soluble, non-steroidal drug. For the adhesive of the present invention, the lowest layer which is to be contacted with the skin has the lowest water absorption capacity and the most upper layer in contact with the support has the highest water absorption capacity, or vice versa.

Claims

1. A transdermal skin patch to adhere to a patient'"'"'s skin, said skin patch comprising (1) a water-impermeable support or backing layer, (2) a liner, and between the two, (3) a multilayer laminate of from 2 to 5 adhesive layers, each of said adhesive layers comprising an oil-soluble drug, an adhesive resin, a penetration enhancer, a water-absorptive material and a lenitive agent, wherein each adhesive layer contains no water and has a different water absorption capacity in which the lowest layer which is to be contacted with the skin has the lowest water absorption capacity and the most upper layer in contact with the backing layer has the highest water absorption capacity, and the drug is ketoprofen present in an amount of 0.1 to 40% by weight.

2. The transdermal skin patch as claimed in claim 1, wherein the water absorptive material is selected from the group consisting of polyvinyl alcohol, polyvinyl pyrrolidone, alginic acid, hyaluronc acid, cellulose, chitin, zinc oxide, calcium oxide, silica, kaolin, talc and titanium dioxide and is present in an amount of 0.1-30% by weight.

3. A transdermal skin patch to adhere to a patient'"'"'s skin, said skin patch comprising (1) a water-permeable support or backing layer, (2) a liner, and between the two (3) a multilayer laminate having 2 to 5 adhesive layers, each of said adhesive layers comprising an oil-soluble drug, and adhesive resin, a penetration enhancer, a water-absorptive material and a lenitive agent, wherein each adhesive layer contains no water and has a different water absorption capacity in which the lowest layer which is to be contacted with the skin has the highest water absorption capacity and the most upper layer in contact with the backing layer has the lowest water absorption capacity and the drug is ketoprofen present in an amount of 0.1 to 40% by weight.

4. The transdermal skin patch as claimed in claim 3, wherein the water absorptive material is selected from the group consisting of polyvinyl alcohol, polyvinyl pyrrolidone, alginic acid, hyaluronc acid, cellulose, chitin, zinc oxide, calcium oxide, silica, kaolin, talc and titanium dioxide and is present in an amount of 0.1-30% by weight.